Issued Patents All Time
Showing 1–25 of 51 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12331334 | Modified urokinase-type plasminogen activator polypeptides and methods of use | Edwin L. Madison, Christopher D. Thanos, Vanessa Soros, Mikhail Popkov, Kimberly Ann Tipton +2 more | 2025-06-17 |
| 12331099 | VEGF antagonist formulations suitable for intravitreal administration | Daniel Dix, Kenneth S. Graham, Kelly Frye | 2025-06-17 |
| 12116606 | Complement factor I-related compositions and methods | Grant E. BLOUSE, Brajesh KUMAR, Tom KNUDSEN, Jan Kristian JENSEN, Emil OLDENBURG +8 more | 2024-10-15 |
| 11865135 | ß-1,6-glucan therapeutic antibody conjugates | Gabriel O. Reznik, John James Kane, James M. Siedlecki, Zuzana Dostalova, Isabelle Sansal-Castellano +2 more | 2024-01-09 |
| 11732024 | VEGF antagonist formulations suitable for intravitreal administration | Daniel Dix, Kenneth S. Graham, Kelly Frye | 2023-08-22 |
| 11613744 | Modified urokinase-type plasminogen activator polypeptides and methods of use | Edwin L. Madison, Christopher D. Thanos, Vanessa Soros, Mikhail Popkov, Kimberly Ann Tipton +2 more | 2023-03-28 |
| 11459386 | IL-6 antagonists and uses thereof | Michael March Schmidt, Thomas M. Barnes, David V. Erbe, Alison Tisdale | 2022-10-04 |
| 11142571 | IL-6 antibodies | Michael March Schmidt, Alison Tisdale, Grigorios Zarbis-Papastoitsis | 2021-10-12 |
| 11084865 | VEGF antagonist formulations suitable for intravitreal administration | Daniel Dix, Kenneth S. Graham, Kelly Frye | 2021-08-10 |
| 11066458 | VEGF antagonist formulations suitable for intravitreal administration | Daniel Dix, Kenneth S. Graham, Kelly Frye | 2021-07-20 |
| 10934572 | Serum albumin binding molecules | Michael L. Gosselin, David Fabrizio, Joanna Swain, Tracy S. Mitchell, Ray Camphausen +4 more | 2021-03-02 |
| 10774130 | Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins | Ray Camphausen, Irvith M. Carvajal, H. Nicholas Marsh, Marco Gottardis, Joan Carboni +1 more | 2020-09-15 |
| 10711050 | Variant serum albumin with improved half-life and other properties | Michael March Schmidt, Amy Jada Andreucci, Thomas M. Barnes | 2020-07-14 |
| 10603075 | Compositions and methods for enhancing sperm function | Felipe A. Navarrete Solano, Kathleen Seyb | 2020-03-31 |
| 10470798 | Methods for promoting fertilization | Felipe A. Navarrete Solano, Kathleen Seyb | 2019-11-12 |
| 10464992 | VEGF antagonist formulations suitable for intravitreal administration | Daniel Dix, Kenneth S. Graham, Kelly Frye | 2019-11-05 |
| 10400025 | VEGF antagonist formulations suitable for intravitreal administration | Daniel Dix, Kenneth S. Graham, Kelly Frye | 2019-09-03 |
| 10221438 | Serum albumin binding molecules | Michael L. Gosselin, David Fabrizio, Joanna Swain, Tracy S. Mitchell, Ray Camphausen +4 more | 2019-03-05 |
| 9951130 | IL-6 antagonists and uses thereof | Michael March Schmidt, Thomas M. Barnes, David V. Erbe, Alison Tisdale | 2018-04-24 |
| 9914763 | VEGF antagonist formulations suitable for intravitreal administration | Daniel Dix, Kenneth S. Graham, Kelly Frye | 2018-03-13 |
| 9902762 | Multivalent fibronectin based scaffold domain proteins | Ray Camphausen, Irvith M. Carvajal, H. Nicholas Marsh, Marco Gottardis, Joan Carboni +1 more | 2018-02-27 |
| 9580489 | VEGF antagonist formulations suitable for intravitreal administration | Daniel Dix, Kenneth S. Graham, Kelly Frye | 2017-02-28 |
| 9540424 | Serum albumin binding molecules | Michael L. Gosselin, David Fabrizio, Joanna Swain, Tracy S. Mitchell, Ray Camphausen +4 more | 2017-01-10 |
| 9340594 | VEGF antagonist formulations for intravitreal administration | Daniel Dix, Kenneth S. Graham, Kelly Frye | 2016-05-17 |
| 8969289 | Serum albumin binding molecules | Michael L. Gosselin, David Fabrizio, Joanna Swain, Tracy S. Mitchell, Ray Camphausen +4 more | 2015-03-03 |